Assessment of Physical Performance With A Supplementation Containing HMB in a Sample of Old Women in Good Health
HMB
Role of Oral Supplementation of Proteins and β-hydroxy-β-methyl Butyrate (HMB) in a Sample of Older Women in Good Health
1 other identifier
interventional
80
1 country
1
Brief Summary
The purpose of this study is to determine whether a supplementation containing β-Hydroxy-β-methylbutyrate is effective in the treatment of age-related muscle loss in a group of older women compared to a non interventional group
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2014
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2014
CompletedFirst Submitted
Initial submission to the registry
April 16, 2014
CompletedFirst Posted
Study publicly available on registry
April 21, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2014
CompletedDecember 3, 2014
April 1, 2014
4 months
April 16, 2014
December 2, 2014
Conditions
Outcome Measures
Primary Outcomes (1)
Change in Short Physical Performance Battery
Baseline and after 2 months
Study Arms (2)
Control
NO INTERVENTIONHMB
EXPERIMENTALGroup taking oral supplementation with Beta-hydroxy-beta-methylbutyrate
Interventions
Eligibility Criteria
You may qualify if:
- People over 65 years, not residents in nursing home, in good health
- Mini Mental State Examination (corrected for scholarity) more than 23
You may not qualify if:
- Previous oral supplementation with proteins or minerals
- important co-mordidities, such renal or hepatic failure
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Padova
Padua, Padua, 35128, Italy
Related Publications (1)
Berton L, Bano G, Carraro S, Veronese N, Pizzato S, Bolzetta F, De Rui M, Valmorbida E, De Ronch I, Perissinotto E, Coin A, Manzato E, Sergi G. Effect of Oral Beta-Hydroxy-Beta-Methylbutyrate (HMB) Supplementation on Physical Performance in Healthy Old Women Over 65 Years: An Open Label Randomized Controlled Trial. PLoS One. 2015 Nov 3;10(11):e0141757. doi: 10.1371/journal.pone.0141757. eCollection 2015.
PMID: 26529601DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Giuseppe Sergi, MD
University of Padova
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr, PhD
Study Record Dates
First Submitted
April 16, 2014
First Posted
April 21, 2014
Study Start
February 1, 2014
Primary Completion
June 1, 2014
Study Completion
June 1, 2014
Last Updated
December 3, 2014
Record last verified: 2014-04